Rozumenko Artem, Kliuchka Valentyn, Rozumenko Volodymir, Semenova Vera, Kolesnyk Sergii, Fedorenko Zoja
Department of Neuro-Oncology, Romodanov Neurosurgery Institute, 32, Platona Mayborody Street, Kiev, 04050, Ukraine.
Tissue Culture Laboratory, Romodanov Neurosurgery Institute, Kiev, Ukraine.
Neurosurg Rev. 2018 Oct;41(4):1045-1052. doi: 10.1007/s10143-018-0948-y. Epub 2018 Jan 22.
The increased interest in the application of lasers in neuro-oncology prompted us to present our experience of using the laser technologies in the treatment of cerebral gliomas. The aim of the study was to evaluate the clinical efficacy of image-guided laser surface thermal therapy (LSTT) and its influence on survival of patients with glioblastoma (GBM).Data of 91 patients (49 males, 42 females, mean age 51.4 years, range 23-70 years) with supratentorial GBMs located in close vicinity to or within the eloquent brain areas were retrospectively analyzed.All patients were divided into two groups: LSTT group (n = 28) and control group (n = 63). There were no significant differences by gender, age, Karnofsky Performance Scale (KPS) score, and tumor location between groups. Total removal in the LSTT group was performed in 67.9%, in the control group-31.7% (p < 0.01); on the contrary, subtotal removal prevailed in the control group-52.4%; in the LSTT group, it was 32.1%. In postoperative period, there was no significant difference in KPS score between the groups (p = 0.89). A higher degree of resection provided an increase in survival rates (p < 0.01). The median overall survival was 15.5 ± 10.5 months, in the LSTT group 18.4 ± 11.7 and in the control group 14.3 ± 9.1 (p = 0.03). The application of image-guided LSTT in patients with GBMs of eloquent brain areas allowed the high rate of complete resection and improved overall survival without the negative effect on the functional status after surgery.
对激光在神经肿瘤学中应用的兴趣增加促使我们介绍我们在脑胶质瘤治疗中使用激光技术的经验。本研究的目的是评估图像引导激光表面热疗(LSTT)的临床疗效及其对胶质母细胞瘤(GBM)患者生存的影响。对91例幕上GBM患者(49例男性,42例女性,平均年龄51.4岁,范围23 - 70岁)的数据进行回顾性分析,这些患者的肿瘤位于明确脑区附近或内部。所有患者分为两组:LSTT组(n = 28)和对照组(n = 63)。两组在性别、年龄、卡氏功能状态评分(KPS)和肿瘤位置方面无显著差异。LSTT组的全切率为67.9%,对照组为31.7%(p < 0.01);相反,对照组次全切率占主导,为52.4%;LSTT组为32.1%。术后,两组KPS评分无显著差异(p = 0.89)。更高程度的切除可提高生存率(p < 0.01)。中位总生存期为15.5±10.5个月,LSTT组为18.4±11.7个月,对照组为14.3±9.1个月(p = 0.03)。对明确脑区GBM患者应用图像引导LSTT可实现高全切率并改善总生存期,且对术后功能状态无负面影响。